207 related articles for article (PubMed ID: 32444910)
1. ASO Author Reflections: Advances in the Multidisciplinary Management of Intrahepatic Cholangiocarcinoma.
Cloyd JM; Ejaz A; Pawlik TM
Ann Surg Oncol; 2020 Aug; 27(8):2866-2867. PubMed ID: 32444910
[No Abstract] [Full Text] [Related]
2. Multidisciplinary management in the treatment of intrahepatic cholangiocarcinoma.
Ruff SM; Diaz DA; Pitter KL; Hartwell BC; Pawlik TM
CA Cancer J Clin; 2023; 73(4):346-352. PubMed ID: 37046405
[No Abstract] [Full Text] [Related]
3. Cholangiocarcinoma: preventing invasion as anti-cancer strategy.
Gores GJ
J Hepatol; 2003 May; 38(5):671-3. PubMed ID: 12713880
[No Abstract] [Full Text] [Related]
4. ASO Author Reflections: Common, Proliferative, and Inflammatory Subtypes of Intrahepatic Cholangiocarcinoma.
Alaimo L; Moazzam Z; Pawlik TM
Ann Surg Oncol; 2023 Mar; 30(3):1404-1405. PubMed ID: 36376572
[No Abstract] [Full Text] [Related]
5. ASO Author Reflections: Incorporating Circulating Tumor DNA in Perioperative Management of Intrahepatic Cholangiocarcinoma.
Choi WJ; Sapisochin G; O'Kane GM
Ann Surg Oncol; 2023 Jun; 30(6):3864-3865. PubMed ID: 36752965
[No Abstract] [Full Text] [Related]
6. Cholangiocarcinoma: current concepts and insights.
Gores GJ
Hepatology; 2003 May; 37(5):961-9. PubMed ID: 12717374
[No Abstract] [Full Text] [Related]
7. ASO Author Reflections: Identification of Intrahepatic Cholangiocarcinoma Clusters Using Machine Learning Techniques: Should Patients be Treated Differently?
Tsilimigras DI; Paredes AZ; Pawlik TM
Ann Surg Oncol; 2020 Dec; 27(13):5233-5234. PubMed ID: 32591955
[No Abstract] [Full Text] [Related]
8. ASO Author Reflections: Intrahepatic Cholangiocarcinoma: Downstaging Strategies Open the Gate to Surgery and Cure.
Boudjema K; Edeline J
Ann Surg Oncol; 2020 Oct; 27(10):3738-3739. PubMed ID: 32314152
[No Abstract] [Full Text] [Related]
9. [Clinical pathology of cholangiocarcinoma (intrahepatic bile duct cancer)].
Yamamoto M
Nihon Geka Hokan; 1995 Nov; 64(6):129-30. PubMed ID: 8913088
[No Abstract] [Full Text] [Related]
10. ASO Author Reflections: Classification of Intrahepatic Cholangiocarcinoma into Perihilar versus Peripheral Subtype.
Wei T; Zhang XF; Pawlik TM
Ann Surg Oncol; 2024 Feb; 31(2):1274-1275. PubMed ID: 37993744
[No Abstract] [Full Text] [Related]
11. ASO Author Reflections: Disparate Outcomes in Stage II Intrahepatic Cholangiocarcinoma: A Case for Upstaging Multifocal Tumors.
Turner KM; Wilson GC
Ann Surg Oncol; 2022 Aug; 29(8):5103-5104. PubMed ID: 35482267
[No Abstract] [Full Text] [Related]
12. ASO Author Reflections: Use of Machine Learning to Predict Early Recurrence After Resection of Intrahepatic Cholangiocarcinoma.
Alaimo L; Pawlik TM
Ann Surg Oncol; 2023 Sep; 30(9):5416-5417. PubMed ID: 37222944
[No Abstract] [Full Text] [Related]
13. ASO Author Reflections: Accuracy of Preoperative Staging and Downstaging After Neoadjuvant Therapy for Resectable Intrahepatic Cholangiocarcinoma.
Alaimo L; Lima HA; Moazzam Z; Pawlik TM
Ann Surg Oncol; 2023 Aug; 30(8):4809-4810. PubMed ID: 37046130
[No Abstract] [Full Text] [Related]
14. ASO Author Reflections: A New Reliable Method of Evaluating Cancer-Associated Fibroblasts in Resected Specimen of Intrahepatic Cholangiocarcinoma.
Eguchi S; Yamada D; Kobayashi S; Sasaki K; Iwagami Y; Tomimaru Y; Noda T; Takahashi H; Asaoka T; Tanemura M; Doki Y; Eguchi H
Ann Surg Oncol; 2023 Sep; 30(9):5429-5430. PubMed ID: 37273026
[No Abstract] [Full Text] [Related]
15. ASO Author Reflections: Adequate Nodal Classification for Perihilar Cholangiocarcinoma.
Sakata J; Takizawa K; Miura K; Hirose Y; Muneoka Y; Tajima Y; Ichikawa H; Shimada Y; Kobayashi T; Wakai T
Ann Surg Oncol; 2023 Jul; 30(7):4318-4319. PubMed ID: 37000358
[No Abstract] [Full Text] [Related]
16. ASO Author Reflections: Higher Tumor Burden Status Dictates the Impact of Surgical Margin Status in Patients with Intrahepatic Cholangiocarcinoma.
Endo Y; Moazzam Z; Lima HA; Pawlik TM
Ann Surg Oncol; 2023 Apr; 30(4):2033-2034. PubMed ID: 36396871
[No Abstract] [Full Text] [Related]
17. ASO Author Reflections: Monitoring the Risk of Recurrence After Curative-Intent Liver Resection for Intrahepatic Cholangiocarcinoma by Applying Hazard Function Analysis.
Alaimo L; Moazzam Z; Pawlik TM
Ann Surg Oncol; 2023 Mar; 30(3):1350-1351. PubMed ID: 36006495
[No Abstract] [Full Text] [Related]
18. ASO Author Reflections: Long-Term Outcomes and Optimal Margin Width Among Patients Undergoing Hepatectomy for Intrahepatic Cholangiocarcinoma.
Alaimo L; Moazzam Z; Pawlik TM
Ann Surg Oncol; 2023 Jul; 30(7):4302-4303. PubMed ID: 36964330
[No Abstract] [Full Text] [Related]
19. ASO Author Reflections: Usage of Hepatic Arterial Infusion Pump Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma.
Holster JJ; Groot Koerkamp B
Ann Surg Oncol; 2022 Sep; 29(9):5539-5540. PubMed ID: 35266080
[No Abstract] [Full Text] [Related]
20. ASO Author Reflections: Robotic Approach for Perihilar Cholangiocarcinoma.
Ielpo B; Rosso E; d'Addetta MV; Abad M; Vellalta G; Sanchez-Velazquez P; Burdio F
Ann Surg Oncol; 2024 May; 31(5):3106-3107. PubMed ID: 38334849
[No Abstract] [Full Text] [Related]
[Next] [New Search]
